Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease

BACKGROUND: We investigated whether combinations of serum cytokines, used with logistic disease predictor models, could facilitate the detection of pancreatic ductal adenocarcinoma (PDAC). METHODS: The serum levels of 27 cytokines were measured in 241 subjects, 127 with PDAC, 49 with chronic pancrea...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Shaw, Victoria E, Lane, Brian, Jenkinson, Claire, Cox, Trevor, Greenhalf, William, Halloran, Christopher M, Tang, Joseph, Sutton, Robert, Neoptolemos, John P, Costello, Eithne
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2014
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4032456/
https://ncbi.nlm.nih.gov/pubmed/24884871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-13-114
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы